Paper36419829
TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
Zou X and 2 others. Front Genet, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer. Papers, record 36419829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36419829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33176521 | M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma. | Cancer Invest | 2021 | https://conductscience.org/library/papers/33176521 | PubMed |
| 2 | 29092952 | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092952 | PubMed |
| 3 | 30861269 | Immune infiltration in renal cell carcinoma. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30861269 | PubMed |
| 4 | 32093313 | TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32093313 | PubMed |
| 5 | 15454922 | Toll-like receptor control of the adaptive immune responses. | Nat Immunol | 2004 | https://conductscience.org/library/papers/15454922 | PubMed |
| 6 | 33564310 | ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19. | J Oncol | 2021 | https://conductscience.org/library/papers/33564310 | PubMed |
| 7 | 31701128 | DriverDBv3: a multi-omics database for cancer driver gene research. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/31701128 | PubMed |
| 8 | 35127830 | Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35127830 | PubMed |
| 9 | 33310018 | FunRich enables enrichment analysis of OMICs datasets. | J Mol Biol | 2021 | https://conductscience.org/library/papers/33310018 | PubMed |
| 10 | 20930504 | Anticancer function of polyinosinic-polycytidylic acid. | Cancer Biol Ther | 2010 | https://conductscience.org/library/papers/20930504 | PubMed |
| 11 | 34258261 | CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34258261 | PubMed |
| 12 | 23851493 | The immune network in pancreatic cancer development and progression. | Oncogene | 2014 | https://conductscience.org/library/papers/23851493 | PubMed |
| 13 | 32209603 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/32209603 | PubMed |
| 14 | 31988496 | RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. | Cell Death Differ | 2020 | https://conductscience.org/library/papers/31988496 | PubMed |
| 15 | 27993630 | Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma. | EBioMedicine | 2017 | https://conductscience.org/library/papers/27993630 | PubMed |
| 16 | 30527665 | Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. | Mol Cell | 2019 | https://conductscience.org/library/papers/30527665 | PubMed |
| 17 | 29170066 | Glioma epigenetics: From subclassification to novel treatment options. | Semin Cancer Biol | 2018 | https://conductscience.org/library/papers/29170066 | PubMed |
| 18 | 28579323 | Type I Interferon in Chronic Virus Infection and Cancer. | Trends Immunol | 2017 | https://conductscience.org/library/papers/28579323 | PubMed |
| 19 | 31881506 | Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma. | Transl Oncol | 2020 | https://conductscience.org/library/papers/31881506 | PubMed |
| 20 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41063980 | Mendelian randomization combined with single-cell sequencing analysis revealed prognostic genes related to myeloid cell differentiation in prostate cancer and experimental verification. | Front Immunol | 2025 | https://conductscience.org/library/papers/41063980 | PubMed |
| 40838069 | Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade Glioma. | Biomed Res Int | 2025 | https://conductscience.org/library/papers/40838069 | PubMed |
| 40716784 | CCR2 and TLR3: noninvasive macrophage-associated biomarkers of acute renal transplant rejection. | Ren Fail | 2025 | https://conductscience.org/library/papers/40716784 | PubMed |
| 40535567 | Mechanistic insights curcumin's anti-inflammatory in pancreatic cancer: experimental and computational evidence implicating IL1B interference via IL10RA upregulation and NLRP3/TLR3 downregulation. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40535567 | PubMed |
| 39280680 | Identification and expression of prognostic-related genes in kidney renal clear cell carcinoma and their possible regulatory mechanisms. | Transl Androl Urol | 2024 | https://conductscience.org/library/papers/39280680 | PubMed |
| 38856710 | Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/38856710 | PubMed |
| 37504335 | Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37504335 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36419829
GET https://conductscience.org/api/papers/v1/36419829/references?page=2